Editorial Board for section 'Leukemias'
- Chronic Myeloid Disease Section
- Coagulation Section
- Leukemias Section
- Lymphomas Section
- Plasma Cell Disorders Section
- Radiolabeled Blood Elements and Other Imaging Modalities Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Interests: experimental therapeutics; acute leukemias; myeloproliferative diseases
Interests: experimental therapeutics; acute leukemias; myeloproliferative diseases
Massachusetts General Hospital Cancer Center, Harvard Medical School, 0 Emerson Place, Suite 118, Boston, MA 02114, USA
Interests: IDH-inhibition; aurora kinase inhibition; FLT3 inhibition; antibody-drug conjugates; novel therapeutic approaches; acute leukemias
Interests: IDH-inhibition; aurora kinase inhibition; FLT3 inhibition; antibody-drug conjugates; novel therapeutic approaches; acute leukemias
Tenured Professor of Pathology Chair, Department of Pathology P.L. Foster School of Medicine Texas Tech University Health Sciences Center, El Paso, TX, USA
Interests: myeloid neoplasms; spleen pathology; lymphoid neoplasms
Interests: myeloid neoplasms; spleen pathology; lymphoid neoplasms
Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Medical and Surgical Sciences (DIMEC), Bologna University, Bologna, Italy
Interests: leukemia; lymphoma; targeted therapy; molecular diagnostics; high throughput genomics; transcriptomics
Special Issues, Collections and Topics in MDPI journals
Interests: leukemia; lymphoma; targeted therapy; molecular diagnostics; high throughput genomics; transcriptomics
Special Issues, Collections and Topics in MDPI journals
Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Interests: acute myeloid leukemia; aplastic anemia; myelodysplastic syndromes; myeloproliferative neoplasms; paroxysmal nocturnal hemoglobinuria
Interests: acute myeloid leukemia; aplastic anemia; myelodysplastic syndromes; myeloproliferative neoplasms; paroxysmal nocturnal hemoglobinuria
Preclinical Models and Clinical Trials in Oncology and Hematology, Istituto Superiore di Sanità, Rome, Italy
Interests: acute myeloid leukemia; normal and leukemic stem cells; hematopoietic differentiation; cell differentiation therapy; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Interests: acute myeloid leukemia; normal and leukemic stem cells; hematopoietic differentiation; cell differentiation therapy; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA
Interests: acute myeloid leukemia; antibody-based therapy; CD33; clinical trials; minimal residual disease
Special Issues, Collections and Topics in MDPI journals
Interests: acute myeloid leukemia; antibody-based therapy; CD33; clinical trials; minimal residual disease
Special Issues, Collections and Topics in MDPI journals
Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Interests: role of angiogenesis in promoting the growth of hematological malignancies; screening anti-angiogenic and other biological agents for effects on clinically relevant human leukemia in vivo; early stage clinical trials for acute leukemia
Interests: role of angiogenesis in promoting the growth of hematological malignancies; screening anti-angiogenic and other biological agents for effects on clinically relevant human leukemia in vivo; early stage clinical trials for acute leukemia
Section of Hematology, Department of Internal Medicine, Yale University, New Haven, CT, USA.
Interests: hematologic neoplasms; translational medical research; MDS; AML; clinical research; novel therapies
Interests: hematologic neoplasms; translational medical research; MDS; AML; clinical research; novel therapies
